Neflumozide
Neflumozide is a pharmaceutical compound that has been studied for its potential therapeutic effects. It is classified under the category of antineoplastic agents, which are drugs used to treat cancer by inhibiting the growth of malignant cells.
Mechanism of Action[edit]
Neflumozide works by interfering with the cell cycle of cancer cells, thereby preventing their proliferation. The exact molecular mechanism is still under investigation, but it is believed to target specific enzymes involved in cell division.
Clinical Trials[edit]
Several clinical trials have been conducted to evaluate the efficacy and safety of Neflumozide in treating various types of cancer, including breast cancer, lung cancer, and colorectal cancer. Preliminary results have shown promise, but further studies are needed to confirm its effectiveness and determine the optimal dosage.
Side Effects[edit]
Like many antineoplastic agents, Neflumozide can cause a range of side effects. Common side effects include nausea, vomiting, fatigue, and hair loss. More severe side effects may include neutropenia, anemia, and thrombocytopenia.
Pharmacokinetics[edit]
The pharmacokinetics of Neflumozide involve its absorption, distribution, metabolism, and excretion. It is typically administered intravenously, and its bioavailability is nearly 100%. The drug is metabolized primarily in the liver and excreted through the kidneys.
Related Compounds[edit]
Neflumozide is structurally related to other antineoplastic agents such as doxorubicin and paclitaxel. These compounds share similar mechanisms of action and are often used in combination therapies to enhance treatment efficacy.
Future Research[edit]
Ongoing research aims to better understand the molecular targets of Neflumozide and to develop more effective treatment protocols. Studies are also exploring its potential use in combination with other therapeutic agents to improve patient outcomes.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
-
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers a medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Budget GLP1 shots (generic and brand names) such as
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Budget GLP1 weight loss injections NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
- Tags:
Budget glp1 weight loss NYC, Zepbound NYC, Philadelphia medical weight loss, Wegovy NYC, Zepbound NYC, Budget GLP1 shots Philadelphia
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
